NeuroConnect
- When: 20 November 2025 | 10:00-18:00
- Where: Kempenhaeghe Epilepsy and Sleep Center | Parking: because of limited parking spaces, please come by public transport
- For whom: This event is organised for all MedTech stakeholders, such as technical and clinical researchers, clinical physicists, physicians, industry, health insurers, politicians etc.
- Language: English
Neuromodulation Strategies for Intractable Migraine: A New Frontier
Daniel Schobben is one of the founders of Salvia BioElectronics (2017) and is passionately committed to restoring hope, health, and happiness for people with chronic migraine and chronic cluster headache. At Salvia, he drives innovation by translating stakeholder needs to pragmatic product concepts.
Prior to founding Salvia, he has taken on roles in product management, M&A due diligence, innovation management, and interim leadership. He has coordinated venture portfolios and founded, chaired, and advised companies, with a particular focus on medical devices over the past decade. He started his career at Philips, where over 200 patents were filed based on his work. Daniel holds MSc and PhD degrees in Electrical Engineering from the Eindhoven University of Technology.
More information
Check the webpage of the event.